London close: Stocks pare gains after US data
1st May 2013 16:40
Disappointing economic from the States saw the FTSE 100 halve its earlier gains by the close on Wednesday as markets waited in anticipation of a policy decision from the Federal Reserve later this evening. The US central bank is widely expected to leave its current stimulus measures unchanged follo
Read moreLondon midday: Stocks extend gains ahead of Fed decision
1st May 2013 11:27
The FTSE 100 was taking advantage of low volumes on Wednesday morning, registering decent gains by lunchtime as other stock markets across Europe remained closed for the May Day public holiday. A slowdown in Chinese manufacturing growth didn't have too much of an effect on markets early on as trade
Read moreLondon open: Miners shrug off disappointing Chinese data
1st May 2013 08:21
A slowdown in Chinese manufacturing growth didn't have too much of an effect on stock markets on Wednesday morning as traders showed optimism in anticipation of a continuation of monetary stimulus from the US and a rate cut in Europe this week. Nevertheless, volumes are expected to be low today giv
Read moreMonday broker round-up UPDATE
25th Mar 2013 07:12
Amur Minerals Corporation: HB Markets initiates with a speculative buy. ARM Holdings: Bank of America Merrill Lynch reiterates buy and 1,145p price target. AstraZeneca: Deutsche Bank raises target price from 2800p to 3100p and keeps a hold recommendation. Exane BNP ups target price from 3100p to 3
Read moreTyman's restructuring opens door to higher annual profits
12th Mar 2013 13:28
Tyman, supplier of door and window components, reported a rise in 2012 revenues following improved performance in North America. Revenues grew 5.8% year-on-year from £216.3m to £228.8m as the company underwent a major restructuring and changed its name from Lupus Capital to Tyman to reflect the bu
Read moreTuesday broker round-up UPDATE
12th Mar 2013 07:19
Abcam:Investec shifts target price from 484p to 487p and keeps a buy recommendation. Admiral Group: UBS ups target price from 1200p to 1275p and reiterates a neutral rating. Amlin: Westhouse Securities raises target price from 440p to 455p, but downgrades from add to neutral. Anite: Numis reduce
Read more